February
Thursday 15 February 2018 photo 6/14
|
Canadian diabetes guidelines asa: >> http://hda.cloudz.pw/download?file=canadian+diabetes+guidelines+asa << (Download)
Canadian diabetes guidelines asa: >> http://hda.cloudz.pw/read?file=canadian+diabetes+guidelines+asa << (Read Online)
vascular protection in people with diabetes
cholesterol targets diabetes canada
vascular protection in diabetes
what is vascular protection
canadian diabetes guidelines statin
canadian diabetes association clinical practice guidelines 2014
aspirin guidelines canada
diabetes canada vascular protection checklist
A1C (%) Standardized, validated assay, in the absence of factors that affect the accuracy of A1C and not for suspected type 1 diabetes. 6.0 – 6.4. Prediabetes. ?6.5 . in people with diabetes. ASA may be used for secondary prevention. YES. YES. YES. YES. STATIN*. +. ACEi or ARB#. +. ASA. Clopidrogrel if ASA-intolerant.
* Dose adjustments or additional lipid therapy warranted if lipid target (LDL-C ?2.0 mmol/L) not being met. ASA should not be used for the primary prevention of cardiovascular disease in people with diabetes. ASA may be used for secondary prevention.
The clinical trial evidence, as reflected in the 2011 Canadian Cardiovascular Society Guidelines on the Use of Antiplatelet Therapy in the Outpatient Setting, supports the use of ASA 75 to 162 mg daily for the secondary prevention of CAD events in those with diabetes (41) .
Does the patient have macrovascular disease? Cardiac ischemia (silent or overt); Peripheral arterial disease; Cerebrovascular/Carotid disease. Yes No. Does the patient have microvascular disease? Retinopathy; Nephropathy (ACR ? 2.0); Neuropathy. Yes No. What is the patient's age? years. Does the patient
MD follows clinical practice guidelines. 8-year follow-up composite outcome: CV death, MI, CABG, PCI, Stroke, Amputation, or PVD surgery. Gaede et al. NEJM. 2003: 348;383-393. Intensive Arm. Therapies to achieve targets in glycemia, lipids, BP and microalbuminuria. Multidisciplinary care q3mo. ASA and ACE inhibitors.
Drugs to protect your heart: Blood pressure pills (ACE inhibitors or ARBs), cholesterol lowering pills (statins), or ASA (Aspirin). These drugs will protect your heart even if your blood pressure or cholesterol is already at target.
1 Jul 2010 A recent meta-analysis combined JPAD1 and POPADAD2 with subgroups of patients with diabetes extracted from other studies and also found no overall advantage for ASA in primary prevention for those with type 2 diabetes.4. Canadian Diabetes Association guidelines5 correctly suggest that ASA is not
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Richard E. Gilbert MBBS, PhD, Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351:1755-62.
of cardiovascular disease (CVD), including myocar- dial infarction (MI) and stroke, is likely something that comes up frequently at family physician appointments. Acetylsalicylic acid has substantial benefits for second- ary prevention in most cases. Based on current recom- mendations, most would also agree that the benefits.
ASA should not be routinely used for the primary prevention of cardiovascular disease in people with diabetes [Grade A, Level 2 (36) ]. Low-dose ASA therapy (81–325 mg) may be used for secondary prevention in people with established cardiovascular disease [Grade D, Consensus].
Annons
Visa toppen
Show footer